Causeway Capital CEO on Value Opportunities Outside US
Original Report
Causeway Capital Management CEO & Fundamental Portfolio Manager Sarah H. Ketterer discusses risks and opportunities across global markets and how investors can look beyond concentrated AI megacaps...
Causeway Capital Management CEO & Fundamental Portfolio Manager Sarah H. Ketterer discusses risks and opportunities across global markets and how investors can look beyond concentrated AI megacaps with Bloomberg’s Hema Parmar at Bloomberg Invest Dallas 2026. (Source: Bloomberg)
Glass House Analysis
International economic policy has concrete impacts far beyond diplomatic circles. Tariffs show up in the price of goods at stores, supply chain disruptions affect whether products are on shelves, and trade tensions can mean job losses in export-dependent industries. The globalized economy means that decisions made abroad can affect workers and consumers domestically.
Corporate decisions reverberate through local communities—a merger might mean headquarters relocating, a restructuring could eliminate jobs, and strategic shifts affect suppliers and service providers in countless towns. Behind quarterly earnings numbers are real employment decisions, investment choices, and community impacts that shape the economic landscape of regions across the country.
The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.
Enjoyed this analysis?
Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.
No spam. Unsubscribe anytime.
More Stories
CNBC Workforce Executive Summit live updates: AI and the future of work
Follow CNBC's 2026 Workforce Executive Summit for live updates on Walmart's AI strategy, changing job skills, hiring, employee benefits and the future of work.
I just bought this pharma stock for its next generation of blockbuster drugs — and its dividend
AbbVie is entering a new chapter of growth, fueled by its blockbuster immunology drugs and expanding neuroscience business. Investor Kevin Simpson shares why he's optimistic.
Speaker Mike Johnson calls election-transfer concerns ‘absurd’
Democrats and voting rights groups have raised concerns that President Donald Trump and congressional Republicans could challenge election results if they lose.
Coffee Break: Armed Madhouse – Tactical Nuclear Weapons: A Deadly Temptation
Originally developed as battlefield weapons, tactical nuclear arms have acquired a new rationale as instruments of incremental deterrence and escalation control. The revival of low-yield nuclear...